Return to work after breast cancer diagnosis: An observational prospective study in Brazil

Background In North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Vol. 124; no. 24; pp. 4700 - 4710
Main Authors: Landeiro, Luciana C. G., Gagliato, Debora M., Fêde, Angelo B., Fraile, Natalia M., Lopez, Rossana M., da Fonseca, Leonardo G., Petry, Vanessa, Testa, Laura, Hoff, Paulo M., Mano, Max S.
Format: Journal Article
Language:English
Published: United States Wiley Subscription Services, Inc 15-12-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background In North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary objectives of this study were to define RTW rates at 12 and 24 months after BC diagnosis and to identify the factors associated with RTW in this population. Methods In total, 125 employed women from a single institution with newly diagnosed BC were interviewed by telephone at 6, 12, and 24 months after diagnosis. Those who had inoperable or metastatic disease were excluded. Results Overall, RTW rates were 30.3% and 60.4% at 12 and 24 months after BC diagnosis, respectively. Most women reported that they received support from their employer, but only 29.1% reported having been offered work adjustments. In multivariate analysis, the factors associated with positive RTW outcomes included higher household income (odds ratio [OR], 17.76; 95% confidence interval [CI], 3.33‐94.75; P = .001), breast‐conserving surgery (OR, 9.77; 95% CI, 2.03‐47.05; P = .004), and work adjustments (OR, 37.62; 95% CI, 2.03‐47.05; P = .004). The factors associated with negative RTW outcomes included adjuvant endocrine therapy (OR, 0.11; 95% CI, 0.02‐0.74; P = .023), and depression diagnosed after BC (OR, 0.07; 95% CI, 0.01‐0.63; P = .017). Conclusions RTW rates in the current study were lower than those observed in developed countries but similar to the rates among low‐income Americans. Workplace adjustments, higher income, breast‐conserving surgery, endocrine therapy, and depression after BC played an important role in the RTW decision. After a diagnosis of breast cancer, return‐to‐work rates among Latin Americans appear to be lower than those observed in developed countries but similar to those in low‐income North Americans. Workplace adjustments, higher household income, breast‐conserving surgery, endocrine therapy, and depression after diagnosis play important roles in the decision to return to work.
AbstractList BACKGROUNDIn North America and Europe, return-to-work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary objectives of this study were to define RTW rates at 12 and 24 months after BC diagnosis and to identify the factors associated with RTW in this population. METHODSIn total, 125 employed women from a single institution with newly diagnosed BC were interviewed by telephone at 6, 12, and 24 months after diagnosis. Those who had inoperable or metastatic disease were excluded. RESULTSOverall, RTW rates were 30.3% and 60.4% at 12 and 24 months after BC diagnosis, respectively. Most women reported that they received support from their employer, but only 29.1% reported having been offered work adjustments. In multivariate analysis, the factors associated with positive RTW outcomes included higher household income (odds ratio [OR], 17.76; 95% confidence interval [CI], 3.33-94.75; P = .001), breast-conserving surgery (OR, 9.77; 95% CI, 2.03-47.05; P = .004), and work adjustments (OR, 37.62; 95% CI, 2.03-47.05; P = .004). The factors associated with negative RTW outcomes included adjuvant endocrine therapy (OR, 0.11; 95% CI, 0.02-0.74; P = .023), and depression diagnosed after BC (OR, 0.07; 95% CI, 0.01-0.63; P = .017). CONCLUSIONSRTW rates in the current study were lower than those observed in developed countries but similar to the rates among low-income Americans. Workplace adjustments, higher income, breast-conserving surgery, endocrine therapy, and depression after BC played an important role in the RTW decision.
Background In North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary objectives of this study were to define RTW rates at 12 and 24 months after BC diagnosis and to identify the factors associated with RTW in this population. Methods In total, 125 employed women from a single institution with newly diagnosed BC were interviewed by telephone at 6, 12, and 24 months after diagnosis. Those who had inoperable or metastatic disease were excluded. Results Overall, RTW rates were 30.3% and 60.4% at 12 and 24 months after BC diagnosis, respectively. Most women reported that they received support from their employer, but only 29.1% reported having been offered work adjustments. In multivariate analysis, the factors associated with positive RTW outcomes included higher household income (odds ratio [OR], 17.76; 95% confidence interval [CI], 3.33‐94.75; P = .001), breast‐conserving surgery (OR, 9.77; 95% CI, 2.03‐47.05; P = .004), and work adjustments (OR, 37.62; 95% CI, 2.03‐47.05; P = .004). The factors associated with negative RTW outcomes included adjuvant endocrine therapy (OR, 0.11; 95% CI, 0.02‐0.74; P = .023), and depression diagnosed after BC (OR, 0.07; 95% CI, 0.01‐0.63; P = .017). Conclusions RTW rates in the current study were lower than those observed in developed countries but similar to the rates among low‐income Americans. Workplace adjustments, higher income, breast‐conserving surgery, endocrine therapy, and depression after BC played an important role in the RTW decision. After a diagnosis of breast cancer, return‐to‐work rates among Latin Americans appear to be lower than those observed in developed countries but similar to those in low‐income North Americans. Workplace adjustments, higher household income, breast‐conserving surgery, endocrine therapy, and depression after diagnosis play important roles in the decision to return to work.
After a diagnosis of breast cancer, return‐to‐work rates among Latin Americans appear to be lower than those observed in developed countries but similar to those in low‐income North Americans. Workplace adjustments, higher household income, breast‐conserving surgery, endocrine therapy, and depression after diagnosis play important roles in the decision to return to work.
In North America and Europe, return-to-work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary objectives of this study were to define RTW rates at 12 and 24 months after BC diagnosis and to identify the factors associated with RTW in this population. In total, 125 employed women from a single institution with newly diagnosed BC were interviewed by telephone at 6, 12, and 24 months after diagnosis. Those who had inoperable or metastatic disease were excluded. Overall, RTW rates were 30.3% and 60.4% at 12 and 24 months after BC diagnosis, respectively. Most women reported that they received support from their employer, but only 29.1% reported having been offered work adjustments. In multivariate analysis, the factors associated with positive RTW outcomes included higher household income (odds ratio [OR], 17.76; 95% confidence interval [CI], 3.33-94.75; P = .001), breast-conserving surgery (OR, 9.77; 95% CI, 2.03-47.05; P = .004), and work adjustments (OR, 37.62; 95% CI, 2.03-47.05; P = .004). The factors associated with negative RTW outcomes included adjuvant endocrine therapy (OR, 0.11; 95% CI, 0.02-0.74; P = .023), and depression diagnosed after BC (OR, 0.07; 95% CI, 0.01-0.63; P = .017). RTW rates in the current study were lower than those observed in developed countries but similar to the rates among low-income Americans. Workplace adjustments, higher income, breast-conserving surgery, endocrine therapy, and depression after BC played an important role in the RTW decision.
Author Lopez, Rossana M.
da Fonseca, Leonardo G.
Gagliato, Debora M.
Petry, Vanessa
Fêde, Angelo B.
Landeiro, Luciana C. G.
Testa, Laura
Fraile, Natalia M.
Hoff, Paulo M.
Mano, Max S.
Author_xml – sequence: 1
  givenname: Luciana C. G.
  surname: Landeiro
  fullname: Landeiro, Luciana C. G.
  email: luciana.landeiro@nob-ba.com.br
  organization: Sao Paulo State Cancer Institute
– sequence: 2
  givenname: Debora M.
  surname: Gagliato
  fullname: Gagliato, Debora M.
  organization: Sao Paulo State Cancer Institute
– sequence: 3
  givenname: Angelo B.
  surname: Fêde
  fullname: Fêde, Angelo B.
  organization: Sao Paulo State Cancer Institute
– sequence: 4
  givenname: Natalia M.
  surname: Fraile
  fullname: Fraile, Natalia M.
  organization: Sao Paulo State Cancer Institute
– sequence: 5
  givenname: Rossana M.
  surname: Lopez
  fullname: Lopez, Rossana M.
  organization: Sao Paulo State Cancer Institute
– sequence: 6
  givenname: Leonardo G.
  surname: da Fonseca
  fullname: da Fonseca, Leonardo G.
  organization: Sao Paulo State Cancer Institute
– sequence: 7
  givenname: Vanessa
  surname: Petry
  fullname: Petry, Vanessa
  organization: Sao Paulo State Cancer Institute
– sequence: 8
  givenname: Laura
  surname: Testa
  fullname: Testa, Laura
  organization: Sao Paulo State Cancer Institute
– sequence: 9
  givenname: Paulo M.
  surname: Hoff
  fullname: Hoff, Paulo M.
  organization: Sao Paulo State Cancer Institute
– sequence: 10
  givenname: Max S.
  surname: Mano
  fullname: Mano, Max S.
  organization: Sao Paulo State Cancer Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30329152$$D View this record in MEDLINE/PubMed
BookMark eNp90EtLAzEQB_AgFa2Pix9AAl5E2JrHPr3V4guKgiiIl2U2Oyup26Qmu0r99EarHjx4GgZ-_Jn5b5GBsQYJ2eNsxBkTx8ooN5I8k8kaGXJWZBHjsRiQIWMsj5JYPmySLe9nYc1EIjfIpmRSFDwRQ_J4i13vDO0sfbPumULToaOVQ_AdVWBU2GoNT8Z67U_o2FBbeXSv0GlroKULZ_0CVadfkfqur5dUG3rq4F23O2S9gdbj7vfcJvfnZ3eTy2h6c3E1GU8jFSdFEsUKKy5zJnJUBaAEKFIGTcriRsQ1ihoamTYc07ouhOAyZZXIMwUSMlB5k8ptcrjKDbe89Oi7cq69wrYFg7b3peCCx4VIMx7owR86s-H7cF1QSVKkQcqgjlZKhee8w6ZcOD0Htyw5Kz8bLz8bL78aD3j_O7Kv5lj_0p-KA-Ar8KZbXP4TVU6uJ7er0A-Gj414
CitedBy_id crossref_primary_10_5205_1981_8963_2024_259476
crossref_primary_10_1007_s10549_022_06599_z
crossref_primary_10_1200_GO_20_00566
crossref_primary_10_61622_rbgo_2024rbgo60
crossref_primary_10_1155_2023_9345780
crossref_primary_10_1539_sangyoeisei_2020_039_B
crossref_primary_10_1007_s10926_020_09881_3
crossref_primary_10_1136_jech_2021_218331
crossref_primary_10_1080_10803548_2022_2044640
crossref_primary_10_1200_JGO_19_00243
crossref_primary_10_1016_j_arcmed_2022_11_013
crossref_primary_10_1007_s00520_021_06354_y
crossref_primary_10_1200_JGO_19_00263
crossref_primary_10_1038_s41409_021_01429_0
crossref_primary_10_1007_s11764_021_01097_5
crossref_primary_10_1007_s11764_020_00862_2
crossref_primary_10_1007_s00520_020_05640_5
crossref_primary_10_1200_GO_21_00223
crossref_primary_10_1016_j_breast_2019_07_007
crossref_primary_10_2196_31966
crossref_primary_10_1111_bjhp_12623
crossref_primary_10_1007_s00520_019_05164_7
crossref_primary_10_1002_pon_5753
crossref_primary_10_3390_curroncol28050330
crossref_primary_10_1007_s00520_024_08409_2
crossref_primary_10_1111_ecc_13353
crossref_primary_10_1007_s11764_023_01421_1
crossref_primary_10_3390_curroncol29030173
crossref_primary_10_3390_ijerph20054225
Cites_doi 10.1002/1097-0142(19900201)65:3 <742::AID-CNCR2820651319>3.0.CO;2-P
10.1200/JCO.2005.09.500
10.1002/ijc.29210
10.1002/cncr.26478
10.1200/JCO.1997.15.3.974
10.1007/s10926-009-9215-y
10.1016/S0140-6736(14)62038-9
10.1007/s10926-016-9685-7
10.1002/pon.3157
10.1007/s10549-008-0209-9
10.1038/bjc.2015.431
10.1200/JCO.2011.41.4375
10.1007/s00520-014-2474-y
10.3233/WOR-2011-1137
10.1200/JCO.2004.00.4929
10.3322/caac.21262
10.1056/NEJMoa050518
10.1002/cncr.28607
10.1093/annonc/mdq556
10.1055/s-0038-1624580
10.1377/hlthaff.2016.1196
10.1634/theoncologist.2013-0321
10.1002/cncr.20564
10.1158/1055-9965.EPI-12-1356
10.3322/caac.20107
10.1007/s10549-013-2625-8
10.1590/1413-81232015212.19422015
10.1016/S0140-6736(05)66544-0
10.1038/35021093
ContentType Journal Article
Copyright 2018 American Cancer Society
2018 American Cancer Society.
Copyright_xml – notice: 2018 American Cancer Society
– notice: 2018 American Cancer Society.
DBID NPM
AAYXX
CITATION
7TO
7U7
C1K
H94
K9.
NAPCQ
7X8
DOI 10.1002/cncr.31735
DatabaseName PubMed
CrossRef
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts

CrossRef
PubMed
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0142
EndPage 4710
ExternalDocumentID 10_1002_cncr_31735
30329152
CNCR31735
Genre article
Journal Article
GeographicLocations Brazil
GeographicLocations_xml – name: Brazil
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1CY
1L6
1OC
24P
29B
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AARRQ
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHFT
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEIGN
AEIMD
AENEX
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FD6
FUBAC
G-S
G.N
GNP
GODZA
GX1
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
KZ1
L7B
LATKE
LAW
LC2
LC3
LH4
LITHE
LMP
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SJN
SUPJJ
TEORI
UDS
UHB
V2E
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
Z0Y
ZGI
ZZTAW
~IA
~WT
NPM
AAMNL
AAYXX
CITATION
7TO
7U7
C1K
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c4595-4ceb138028ec9ae3aa960af604f24de2daf36f1e6dd9221360b287ca3a7ac8f63
IEDL.DBID 33P
ISSN 0008-543X
IngestDate Sat Aug 17 02:28:31 EDT 2024
Thu Oct 10 22:07:54 EDT 2024
Thu Nov 21 21:21:07 EST 2024
Wed Oct 16 00:52:18 EDT 2024
Sat Aug 24 00:54:34 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 24
Keywords survivorship
breast cancer
return to work
Latin America
Language English
License 2018 American Cancer Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4595-4ceb138028ec9ae3aa960af604f24de2daf36f1e6dd9221360b287ca3a7ac8f63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.31735
PMID 30329152
PQID 2155962143
PQPubID 2045183
PageCount 11
ParticipantIDs proquest_miscellaneous_2121492671
proquest_journals_2155962143
crossref_primary_10_1002_cncr_31735
pubmed_primary_30329152
wiley_primary_10_1002_cncr_31735_CNCR31735
PublicationCentury 2000
PublicationDate December 15, 2018
PublicationDateYYYYMMDD 2018-12-15
PublicationDate_xml – month: 12
  year: 2018
  text: December 15, 2018
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Atlanta
PublicationTitle Cancer
PublicationTitleAlternate Cancer
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2004; 101
2013; 22
2005; 353
2017; 27
2015; 385
2011; 61
2006
2013; 140
2018; 40
2011; 38
2005; 23
2012; 30
2009; 116
2013; 18
2015; 23
2010; 21
1990; 65
2010; 20
1990
2006; 24
2017; 36
2005; 365
2013; 79
2015; 136
1997; 15
2015; 65
2000; 406
2016; 21
2013
2016; 114
2014; 120
2012; 118
Pimenta RBdC (e_1_2_8_26_1) 2013; 79
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
Waddell G (e_1_2_8_15_1) 2006
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
Johnsson A (e_1_2_8_23_1) 2011; 38
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
Lemeshow S (e_1_2_8_18_1) 1990
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_34_1
International Agency for Research on Cancer (IARC), World Health Organization (e_1_2_8_11_1) 2013
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 40
  start-page: 127
  year: 2018
  end-page: 136
  article-title: Late‐stage diagnosis of breast cancer in Brazil: analysis of data from hospital‐based cancer registries (2000–2012)
  publication-title: Rev Bras Ginecol Obstet
– volume: 116
  start-page: 609
  year: 2009
  end-page: 616
  article-title: Impact of breast cancer diagnosis and treatment on work‐related life and factors affecting them
  publication-title: Breast Cancer Res Treat
– volume: 27
  start-page: 547
  year: 2017
  end-page: 558
  article-title: Three‐year prospective cohort study of factors associated with return to work after breast cancer diagnosis
  publication-title: J Occup Rehabil
– volume: 23
  start-page: 889
  year: 2015
  end-page: 898
  article-title: The perceived cancer‐related financial hardship among patients and their families: a systematic review
  publication-title: Support Care Cancer
– volume: 65
  start-page: 87
  year: 2015
  end-page: 108
  article-title: Global cancer statistics, 2012
  publication-title: CA Cancer J Clin
– volume: 22
  start-page: 1411
  year: 2013
  end-page: 1420
  article-title: Employment status and quality of life in recently diagnosed breast cancer survivors
  publication-title: Psychooncology
– volume: 406
  start-page: 747
  year: 2000
  end-page: 752
  article-title: Molecular portraits of human breast tumours
  publication-title: Nature
– volume: 136
  start-page: E359
  year: 2015
  end-page: E386
  article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
  publication-title: Int J Cancer
– year: 1990
– volume: 24
  start-page: 345
  year: 2006
  end-page: 353
  article-title: Correlates of return to work for breast cancer survivors
  publication-title: J Clin Oncol
– volume: 61
  start-page: 69
  year: 2011
  end-page: 90
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
– volume: 15
  start-page: 974
  year: 1997
  end-page: 986
  article-title: Reliability and validity of the Functional Assessment of Cancer Therapy‐Breast quality‐of‐life instrument
  publication-title: J Clin Oncol
– volume: 65
  start-page: 742
  issue: 3 suppl
  year: 1990
  end-page: 751
  article-title: Current issues in cancer rehabilitation
  publication-title: Cancer
– volume: 120
  start-page: 1854
  year: 2014
  end-page: 1862
  article-title: Impact of adjuvant chemotherapy on long‐term employment of survivors of early‐stage breast cancer
  publication-title: Cancer
– volume: 18
  start-page: 1298
  year: 2013
  end-page: 1306
  article-title: Breast cancer in young women in Latin America: an unmet, growing burden
  publication-title: Oncologist
– volume: 22
  start-page: 561
  year: 2013
  end-page: 570
  article-title: Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 114
  start-page: 81
  year: 2016
  end-page: 87
  article-title: Employment and social benefits up to 10 years after breast cancer diagnosis: a population‐based study
  publication-title: Br J Cancer
– year: 2006
– volume: 30
  start-page: 2853
  year: 2012
  end-page: 2860
  article-title: Change in working time in a population‐based cohort of patients with breast cancer
  publication-title: J Clin Oncol
– volume: 23
  start-page: 8305
  year: 2005
  end-page: 8312
  article-title: Not working 3 years after breast cancer: predictors in a population‐based study
  publication-title: J Clin Oncol
– volume: 385
  start-page: 977
  year: 2015
  end-page: 1010
  article-title: CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population‐based registries in 67 countries (CONCORD‐2)
  publication-title: Lancet
– volume: 79
  start-page: 216
  year: 2013
  end-page: 232
  article-title: A Sumula n. 443 do TST e a reintegracao do empregado portador do virus HIV ou de outra doenca grave
  publication-title: Revista do Tribunal Superior do Trabalho
– volume: 140
  start-page: 407
  year: 2013
  end-page: 416
  article-title: Early predictors of not returning to work in low‐income breast cancer survivors: a 5‐year longitudinal study
  publication-title: Breast Cancer Res Treat
– volume: 101
  start-page: 1703
  year: 2004
  end-page: 1711
  article-title: Assessing the impact of cancer on work outcomes: what are the research needs?
  publication-title: Cancer
– volume: 365
  start-page: 1687
  year: 2005
  end-page: 1717
  article-title: Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15‐year survival: an overview of the randomised trials
  publication-title: Lancet
– volume: 353
  start-page: 1784
  year: 2005
  end-page: 1792
  article-title: Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer
  publication-title: N Engl J Med
– volume: 36
  start-page: 274
  year: 2017
  end-page: 281
  article-title: Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment
  publication-title: Health Aff (Millwood)
– volume: 118
  start-page: 1664
  year: 2012
  end-page: 1674
  article-title: Return to work in low‐income Latina and non‐Latina white breast cancer survivors: a 3‐year longitudinal study
  publication-title: Cancer
– volume: 20
  start-page: 49
  year: 2010
  end-page: 58
  article-title: Factors related to return to work by women with breast cancer in northern France
  publication-title: J Occup Rehabil
– volume: 21
  start-page: 351
  year: 2016
  end-page: 370
  article-title: Health, access to services and sources of payment, according to household surveys
  publication-title: Cien Saude Colet
– volume: 38
  start-page: 337
  year: 2011
  end-page: 346
  article-title: Work status and life changes in the first year after breast cancer diagnosis
  publication-title: Work
– volume: 21
  start-page: 2124
  year: 2010
  end-page: 2125
  article-title: Return to work after treatment for breast cancer: single‐center experience in a cohort of 273 patients
  publication-title: Ann Oncol
– year: 2013
– ident: e_1_2_8_13_1
  doi: 10.1002/1097-0142(19900201)65:3 <742::AID-CNCR2820651319>3.0.CO;2-P
– ident: e_1_2_8_20_1
  doi: 10.1200/JCO.2005.09.500
– ident: e_1_2_8_3_1
  doi: 10.1002/ijc.29210
– ident: e_1_2_8_19_1
  doi: 10.1002/cncr.26478
– ident: e_1_2_8_17_1
  doi: 10.1200/JCO.1997.15.3.974
– volume-title: Is Work Good for Your Health and Well‐Being? London
  year: 2006
  ident: e_1_2_8_15_1
  contributor:
    fullname: Waddell G
– ident: e_1_2_8_22_1
  doi: 10.1007/s10926-009-9215-y
– volume-title: Kaggwa S, World Health Organization. Adequacy of Sample Size in Health Studies
  year: 1990
  ident: e_1_2_8_18_1
  contributor:
    fullname: Lemeshow S
– ident: e_1_2_8_10_1
  doi: 10.1016/S0140-6736(14)62038-9
– ident: e_1_2_8_32_1
  doi: 10.1007/s10926-016-9685-7
– volume-title: Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012
  year: 2013
  ident: e_1_2_8_11_1
  contributor:
    fullname: International Agency for Research on Cancer (IARC), World Health Organization
– ident: e_1_2_8_25_1
– ident: e_1_2_8_33_1
  doi: 10.1002/pon.3157
– ident: e_1_2_8_30_1
  doi: 10.1007/s10549-008-0209-9
– ident: e_1_2_8_12_1
  doi: 10.1038/bjc.2015.431
– ident: e_1_2_8_24_1
  doi: 10.1200/JCO.2011.41.4375
– ident: e_1_2_8_14_1
  doi: 10.1007/s00520-014-2474-y
– volume: 38
  start-page: 337
  year: 2011
  ident: e_1_2_8_23_1
  article-title: Work status and life changes in the first year after breast cancer diagnosis
  publication-title: Work
  doi: 10.3233/WOR-2011-1137
  contributor:
    fullname: Johnsson A
– ident: e_1_2_8_21_1
  doi: 10.1200/JCO.2004.00.4929
– ident: e_1_2_8_4_1
  doi: 10.3322/caac.21262
– ident: e_1_2_8_6_1
  doi: 10.1056/NEJMoa050518
– ident: e_1_2_8_28_1
  doi: 10.1002/cncr.28607
– ident: e_1_2_8_29_1
  doi: 10.1093/annonc/mdq556
– ident: e_1_2_8_35_1
  doi: 10.1055/s-0038-1624580
– ident: e_1_2_8_27_1
  doi: 10.1377/hlthaff.2016.1196
– volume: 79
  start-page: 216
  year: 2013
  ident: e_1_2_8_26_1
  article-title: A Sumula n. 443 do TST e a reintegracao do empregado portador do virus HIV ou de outra doenca grave
  publication-title: Revista do Tribunal Superior do Trabalho
  contributor:
    fullname: Pimenta RBdC
– ident: e_1_2_8_5_1
  doi: 10.1634/theoncologist.2013-0321
– ident: e_1_2_8_16_1
  doi: 10.1002/cncr.20564
– ident: e_1_2_8_9_1
  doi: 10.1158/1055-9965.EPI-12-1356
– ident: e_1_2_8_2_1
  doi: 10.3322/caac.20107
– ident: e_1_2_8_31_1
  doi: 10.1007/s10549-013-2625-8
– ident: e_1_2_8_34_1
  doi: 10.1590/1413-81232015212.19422015
– ident: e_1_2_8_8_1
  doi: 10.1016/S0140-6736(05)66544-0
– ident: e_1_2_8_7_1
  doi: 10.1038/35021093
SSID ssj0007253
Score 2.4840477
Snippet Background In North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36...
In North America and Europe, return-to-work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after...
After a diagnosis of breast cancer, return‐to‐work rates among Latin Americans appear to be lower than those observed in developed countries but similar to...
BackgroundIn North America and Europe, return‐to‐work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36...
BACKGROUNDIn North America and Europe, return-to-work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 4700
SubjectTerms Breast cancer
Cancer
Confidence intervals
Developed countries
Diagnosis
Endocrine therapy
Income
Latin America
Medical diagnosis
Mental depression
Metastases
Multivariate analysis
Oncology
return to work
Surgery
survivorship
Therapy
Title Return to work after breast cancer diagnosis: An observational prospective study in Brazil
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.31735
https://www.ncbi.nlm.nih.gov/pubmed/30329152
https://www.proquest.com/docview/2155962143
https://search.proquest.com/docview/2121492671
Volume 124
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFH_oDuLF74_qlIiehLI2adNWvMy5sYtDpsLwUtI0gYF0so-Lf70vadcxBEG8FZI0bd57eb-X5P0CcCNliEAUldePc-4GuYpdIQIMVTh6f0_STAiz4NZ_iQaj-LFraHLul7kwJT9EveBmLMPO18bARTZrrUhDZSGnGHFGzGSYY5hg8zfYcz0NR7SioPRiNwzYqOYmpa1V03Vv9ANiriNW63J6u__72D3YqaAmaZe6sQ8bqjiAradqM_0Q3ocK_U1B5hNiTmcRe104ycwp9TmRRhumJC9P4o1nd6RdkElWr-Hii_E_lnmaxLLUknFBHqbia_xxBG-97mun71ZXLbgyCJPQDSTO2SxGsKFkIhQTAiMbobkXaIoCpLnQjGtf8TxPKPUZ9zIMtaRgIhIy1pwdQ6OYFOoUSCil5-mMJlESBhJbKoEBe6CzLOSaRdqB6-WQp58lo0ZacifT1AxTaofJgeZSGmllVbOUmj1UThHiOXBVF6M9mE0OUajJwtTB8oTyyHfgpJRi3Q26a5ogYHHg1grrl_7TzqAztE9nf6l8DtuIqGJz3sUPm9CYTxfqAjZn-eLSauc3MkLnLQ
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8QwEB48QH3xPuoZ0Seh2CZN2go-6KqsqIt4gPhS0jSBBenKHi_-eidptyKCIL4V0iRtJpP5ZjL5AnCoFEcgipM3TArhR4VOfCkjdFUEWv9A0VxKG3BrP8adl-Ti0tLknI7PwlT8EE3AzWqGW6-tgtuA9PEXa6gqVR9dzpjxSZjGthN3goPdNwtxTGsSyiDxecReGnZSevxV97s9-gEyv2NWZ3SuFv75uYswX6NNclZNjyWY0OUyzNzV--kr8Pqg0eSUZNgjNkGLuBvDSW4T1YdE2QnRJ0WVjNcdnJCzkvTyJoyLDeOPjI9qEkdUS7olOe_Lj-7bKjxfXT612n5924KvIp5yP1K4bLME8YZWqdRMSnRupBFBZCjKkBbSMGFCLYoipTRkIsjR21KSyViqxAi2BlNlr9QbQLhSQWBymsYpjxTW1BJ99sjkOReGxcaDg_GYZ-8VqUZW0SfTzA5T5obJg-2xOLJasQYZtduogiLK82C_KUaVsPscstS9kX0Hy1Mq4tCD9UqMTTdosWmKmMWDIyetX_rPWp3Wg3va_MvLezDbfrq7zW6vOzdbMIcAK7HpLyHfhqlhf6R3YHJQjHbdVP0EzsLrVQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8QwEB48QHzxPuoZ0Seh2OZqK77o6qKoi3iA-FLSNIEF6S57vPjrnbTdigiC-FZI0rSZmcw3yeQLwJHWAoEoKm8Y59LnuYl9pTiGKhK9f6BpppRbcLt-ijqv8eWVo8k5m5yFqfghmgU3ZxnlfO0MvJ_bky_SUF3oAUacERPTMMsRhzvmfMYemnk4ojUHZRD7grPXhpyUnny1_e6OfmDM75C19Dntxf997RIs1FiTnFfKsQxTpliBuft6N30V3h4NOpyCjHrEpWeR8r5wkrk09RHRTh0GJK9S8brDU3JekF7WLOLii_E_Jgc1SUlTS7oFuRioj-77Gry0r55b135914KvuUiEzzVO2ixGtGF0ogxTCkMbZWXALUUJ0lxZJm1oZJ4nlIZMBhnGWloxFSkdW8nWYaboFWYTiNA6CGxGkygRXGNLozBi5zbLhLQssh4cToY87VeUGmlFnkxTN0xpOUwe7EykkdZmNUyp20SVFDGeBwdNMRqE2-VQhemNXR0sT6iMQg82Kik23aC_pgkiFg-OS2H90n_a6rQey6etv1Teh7mHy3Z6d9O53YZ5RFexy30JxQ7MjAZjswvTw3y8VyrqJwcv6fs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Return+to+work+after+breast+cancer+diagnosis%3A+An+observational+prospective+study+in+Brazil&rft.jtitle=Cancer&rft.au=Landeiro%2C+Luciana+C.+G.&rft.au=Gagliato%2C+Debora+M.&rft.au=F%C3%AAde%2C+Angelo+B.&rft.au=Fraile%2C+Natalia+M.&rft.date=2018-12-15&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=124&rft.issue=24&rft.spage=4700&rft.epage=4710&rft_id=info:doi/10.1002%2Fcncr.31735&rft.externalDBID=10.1002%252Fcncr.31735&rft.externalDocID=CNCR31735
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon